
Opinion|Videos|May 3, 2024
Evolving Role of Steroids and Laser In DME
Expert retina speclialists discuss evolving treatment paradigms and the role of intravitreal steroids and macular laser for treating diabetic macular edema.
Advertisement
Episodes in this series

Advertisement
Related to this article

In this Q&A, Ping Moore, OD, covers emerging dry eye therapies, from selenium sulfide to next-gen cyclosporine, and how subtype-guided care shapes treatment choices.

Ophthalmology is projected to face one of the steepest physician shortages of any subspecialty by 2038.

The RMAT designation opens the door to a faster development pathway for EO2002 as a minimally invasive alternative to corneal transplantation, while Emmecell also advances a cell therapy for geographic atrophy.

Andrew G. Lee, MD, and Drew Carey, MD, discuss findings from a retrospective study examining ischemic stroke risk in patients with non-arteritic anterior ischemic optic neuropathy and the implications for vascular risk factor management.

Offline smartphone AI fundus screening detects diabetic retinopathy, glaucoma, and macular degeneration in one capture, delivering high accuracy for low-resource eye care.
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
Johnson & Johnson to acquire Ollin Biosciences in deal worth up to $3.3 billion
2
Q&A: What the FDA’s class-wide NAION warning on GLP-1s means for eye care
3
Dazodalibep data put Sjögren screening in focus for ophthalmologists
4
Q&A: Caroline R. Baumal, MD, from academic retina to the C-suite and back | Eichenbaum Acorns
5


